Assessing topical methylene blue efficacy for radiation-induced oral mucositis pain: a single arm phase ii clinical trial (CTRI/2024/04/065944) (2024)

Government Record · Navas Bright; Cancer Institute (WIA), Chennai (India) · April 18, 2024

Navas Bright et al., 2024-04-18: Indian registry entry for a single-arm phase 2 trial of topical methylene blue for radiation-induced oral mucositis pain at the Cancer Institute (WIA), Chennai, registered prospectively on 18 April 2024.

Assessing topical methylene blue efficacy for radiation-induced oral mucositis pain: a single arm phase ii clinical trial.

Navas Bright et al., 2024-04-18: Indian registry entry for a single-arm phase 2 trial of topical methylene blue for radiation-induced oral mucositis pain at the Cancer Institute (WIA), Chennai, registered prospectively on 18 April 2024. Study type: regulatory record.